Forbes11d
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 Alnylam Pharmaceuticals, Inc. misses on earnings expectations. Reported ...
Business Insider India6y
A 39-year-old who quit school to found his first biotech company now manages $365 million of his own money - here's what he looks for when he invests
in 1999 quit school to help found a biotech company that would eventually become Alnylam. When he sold the company, Angermayer used the funds to launch his family office, which still invests in ...
The Scientist2y
Biopharma Looks to the Netherlands as European Hub
In the fall of 2016, Alnylam Pharmaceuticals was looking to expand ... By the end of the following year, the company had opened offices in Maidenhead, UK; Zug, Switzerland; and Amsterdam, the ...
Houston Chronicle12d
Alnylam: Q4 Earnings Snapshot
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Alnylam Pharmaceuticals Inc. (ALNY) on Thursday reported a loss of $83.8 million in its fourth quarter. On a per-share basis, the Cambridge ...